Drug Price Trends for FT DOCOSANOL

Average Pharmacy Cost for FT DOCOSANOL

These are average pharmacy acquisition costs (net of discounts) from a US national survey

Drug Name	NDC	Price/Unit ($)	Unit	Date
FT DOCOSANOL 10% CREAM	70677-1046-01	6.02264	GM	2024-12-18
FT DOCOSANOL 10% CREAM	70677-1046-01	5.97526	GM	2024-11-20
FT DOCOSANOL 10% CREAM	70677-1046-01	6.08696	GM	2024-10-23
FT DOCOSANOL 10% CREAM	70677-1046-01	6.07323	GM	2024-09-18
FT DOCOSANOL 10% CREAM	70677-1046-01	5.78000	GM	2024-08-21
FT DOCOSANOL 10% CREAM	70677-1046-01	5.79446	GM	2024-07-17
FT DOCOSANOL 10% CREAM	70677-1046-01	5.99016	GM	2024-06-19

Market Analysis and Price Projections for Docosanol

Introduction to Docosanol

Docosanol, marketed under the brand name Abreva, is a topical antiviral drug used to treat recurrent herpes simplex labialis episodes, commonly known as cold sores or fever blisters. It is a saturated 22-carbon aliphatic alcohol that inhibits the fusion between the human cell plasma membrane and the herpes simplex virus (HSV) envelope, preventing viral entry and replication[1][4].

Market Size and Growth

The global market for docosanol cream is experiencing significant growth. As of 2021, the global market for cold sore treatments, including docosanol cream, was valued at approximately $1.6 billion. This market is projected to grow at a remarkable Compound Annual Growth Rate (CAGR) from 2023 to 2031[3].

Market Segmentation

The docosanol cream market is segmented based on several key factors:

• Type: The market is divided into online and offline segments, reflecting the different channels through which the product is sold[2][3].
• Application: The primary application is for the treatment of cold sores and fever blisters[2][3].
• Geography: The market is categorized into regions such as North America, Europe, Asia-Pacific, and the Rest of the World[2][3].

Market Dynamics

Drivers

The increasing demand for effective treatments for cold sores and fever blisters is a major driver of the docosanol cream market. The convenience and efficacy of docosanol in speeding up the healing process and relieving symptoms contribute to its popularity[1][4].

Restraints

Despite its effectiveness, docosanol cannot prevent the occurrence of cold sores or fever blisters, which might limit its market potential. Additionally, the availability of other antiviral treatments could pose competition[1][4].

Opportunities

The market is poised for significant growth due to the expanding global healthcare sector and increasing awareness about the treatment options for herpes simplex infections. Emerging markets in Asia-Pacific and other regions offer lucrative opportunities for growth[2][3].

Challenges

The market faces challenges such as regulatory hurdles, competition from generic or alternative treatments, and the need for continuous innovation to maintain market share[2][3].

Competitive Landscape

The docosanol cream market is dominated by several key players:

• GlaxoSmithKline: One of the major companies behind the brand Abreva[4].
• Aleorderm: Another significant player in the market[2][3].
• Jenson Pharmaceutical Services: Known for their pharmaceutical products, including docosanol cream[2][3].
• PL Developments: A company involved in the development and distribution of pharmaceutical products[2][3].

These companies are profiled in market reports, which include details about their market entry, recent initiatives, collaborations, mergers and acquisitions, and new product launches[2][3].

Price Projections

The retail price of docosanol cream varies depending on the pharmacy and location. Here are some current price points:

• Average Retail Price: Without any discounts, the average retail price of docosanol cream is around $26.26[5].
• Discounted Prices: With discounts from programs like SingleCare, the price can be reduced to as low as $12.13 at participating pharmacies such as CVS, Walmart, and Walgreens[5].

Given the projected market growth, it is likely that the prices will remain competitive, with potential fluctuations based on market dynamics and the introduction of new products.

Market Outlook

The docosanol cream market is expected to experience exponential growth during the forecast period from 2023 to 2031. Here are some key points from the market outlook:

• Revenue Growth: The market is anticipated to develop significant revenue, driven by the increasing demand for effective cold sore treatments[2][3].
• Geographical Expansion: The market is expected to grow across various geographical regions, with Asia-Pacific showing promising growth potential[2][3].
• Product Penetration: The report highlights the penetration of docosanol cream at both national and regional levels, indicating a strong market presence[3].

Key Takeaways

• Market Growth: The docosanol cream market is projected to grow significantly from 2023 to 2031.
• Segmentation: The market is segmented by type, application, and geography.
• Drivers and Restraints: Increasing demand and efficacy drive the market, while limitations in prevention and competition pose restraints.
• Competitive Landscape: Key players include GlaxoSmithKline, Aleorderm, Jenson Pharmaceutical Services, and PL Developments.
• Price Projections: Prices are expected to remain competitive, with discounts available through various programs.

FAQs

1. What is docosanol used for? Docosanol is used for the topical treatment of recurrent herpes simplex labialis episodes, commonly known as cold sores or fever blisters[1][4].

2. How does docosanol work? Docosanol works by inhibiting the fusion between the human cell plasma membrane and the herpes simplex virus (HSV) envelope, preventing viral entry and replication[1][4].

3. Can docosanol prevent cold sores? No, docosanol cannot prevent cold sores or fever blisters from appearing; it only speeds up the healing process and relieves symptoms[1][4].

4. What are the common side effects of docosanol? Common side effects include headache, application site reactions (such as burning or stinging), and herpes simplex outside the treatment area[4].

5. How much does docosanol cream typically cost? The average retail price of docosanol cream is around $26.26, but it can be reduced to as low as $12.13 with discounts from programs like SingleCare[5].

Sources

1. DrugBank: Docosanol: Uses, Interactions, Mechanism of Action.
2. Market Research Intellect: Global Docosanol Cream Market Size, Trends and Projections.
3. Verified Market Reports: Docosanol Cream Market Size, Share, Scope, Trends And Forecast.
4. Pharmacompass: n-Docosanol | Drug Information, Uses, Side Effects, Chemistry.
5. SingleCare: Docosanol Coupons & Prices.